CEPI funding fuels Novavax vaccine trial start, ex-U.S. manufacturing land grab

After enrolling the first volunteers in a Phase I/II trial for its COVID-19 vaccine, Novavax acquired a Czech company that will provide manufacturing capacity outside the U.S., helping the biotech to meet its commitment to provide global access to the vaccine.

On the COVID-19 treatment front, Genentech has partnered with Gilead on severe disease while PureTech is taking aim at complications after the infection clears...